The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects

Biblography

• MAYNARD AD, KUEMPEL ED: Airborne nanostructured particles and occupational health. J. Nanoparticle Res. (2005) 7(6):587-614.
   Web of Science ®Google Scholar
• RABINOW BE: Nanosuspensions in drug delivery. Nature reviews. Drug Discov. (2004) 3(9):785-796.
   Google Scholar
• COURRIER HM, BUTZ N, VANDAMME TF: Pulmonary drug delivery systems: recent developments and prospects. Crit. Rev. Ther. Drug Carrier Syst. (2002) 19(4-5):425-498.
   PubMed Web of Science ®Google Scholar
• KREYLING WG, SEMMLER-BEHNKE M, MOLLER W: Ultrafine particle-lung interactions: does size matter? J. Aerosol Med. (2006) 19(1):74-83.
   PubMedGoogle Scholar
• OBERDÖRSTER G, OBERDÖRSTER E, OBERDÖRSTER J: Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. (2005) 113(7):823-883.
   PubMed Web of Science ®Google Scholar
• GHIRARDELLI R, BONASORO F, PORTA C, CREMASCHI D: Identification of particular epithelial areas and cells that transport polypeptide-coated nanoparticles in the nasal respiratory mucosa of the rabbit. Biochimica et Biophysica Acta (BBA) – Biomembranes (1999) 1416:39-47.
   PubMed Web of Science ®Google Scholar
• HARDY CJ: Nanotoxicology – setting the scene. Proceedings of the Annual Meeting of the Association of Inhalation Toxicologists. Basel, Switzerland (9 – 11 November 2005).
   Google Scholar
• SHEKUNOV B: Nanoparticle technology for drug delivery. From nanoparticles to cutting-edge delivery strategies – Part I. IDrugs (2005) 8:399-401.
   PubMed Web of Science ®Google Scholar
• ZANEN P, GO LT, LAMMERS JWJ: The optimal particle size for β-adrenergic aerosols in mild asthmatics. Int. J. Pharma. (1994) 107(3):211-217.
   Web of Science ®Google Scholar
• STAHLHOFEN W, RUDOLF G, JAMES AC: Intercomparison of experimental regional aerosol depsotion data. J. Aerosol Med. (1989) 2(3):285-305.
   Google Scholar
• LIPPMANN M, YEATES DB, ALBERT RE: Deposition, retention, and clearance of inhaled particles. Br. J. Ind. Med. (1980) 37:337-362.
   PubMedGoogle Scholar
• HEYDER J, GEBHART J, RUDOLF G, SCHILLER CF, STAHLHOFEN W: Deposition of particles in the human respiratory tract in the size range 0.005 – 15 μm. J. Aerosol Soc. (1986) 17(5):811-825.
   Web of Science ®Google Scholar
• CRAMPTON M, KINNERSLEY R, AYRES J: Sub-micrometer particle production by pressurized metered dose inhalers. J. Aerosol Med. (2004) 17(1):33-42.
   PubMedGoogle Scholar
• KIM CS, JAQUES PA: Analysis of total respiratory deposition of inhaled ultrafine particles in adult subjects as various breathing patterns. Aerosol Sci. Technol. (2004) 38(6):525-540.
   Google Scholar
• MORAWSKA L, HOFMANN W, HITCHINS-LOVEDAY J, SWANSON C, MENGERSEN K: Experimental study of the deposition of combustion aerosols in the human respiratory tract. J. Aerosol Sci. (2005) 36(8):939-957.
   Web of Science ®Google Scholar
• SMITH S, CHENG US, YEH HC: Deposition of ultrafine particles in human tracheobronchial airways of adults and children. Aerosol Sci. Technol. (2001) 35(3):697-709.
   Web of Science ®Google Scholar
• HOFMANN W, BERGMANN R, KOBLINGER L: Characterization of local particle deposition patterns in human and rat lungs by different morphometric parameters. J. Aerosol Sci. (1999) 30(5):651-667.
   Web of Science ®Google Scholar
• International Commission on Radiological Protection. Human Respiratory Tract Model for Radiological Protection. Publication 66, Elsevier, Oxford (1994).
   Google Scholar
• WARHEIT DB, HILL LH, GEORGE G, BRODY AR: Time course of chemotactic factor generation and the corresponding macrophage response to asbestos inhalation. Am. Rev. Respir. Dis. (1986) 134:128-133.
   PubMed Web of Science ®Google Scholar
• OBERDÖRSTER G, FERIN J, LEHNERT BE: Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. (1994) 102:173-179.
   PubMed Web of Science ®Google Scholar
• CULLEN RT, TRAN CL, BUCHANAN D et al.: Inhalation of poorly soluble particles. I. Differences in inflammatory response and clearance during exposure. Inhal. Toxicol. (2000) 12:1089-1111.
   PubMed Web of Science ®Google Scholar
• LI XW, LEE DKL, CHAN ASC, OYA-ALPAR H: Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles. Biochimica et Biophysica Acta (BBA) – Gene Struct. Expres. (2003) 1630:7-18.
   PubMed Web of Science ®Google Scholar
• NIKULA KJ, AVILA KJ, GRIFFITH WC, MAUDERLY JL: Lung tissue responses and sites of particle retention differ between rats and Cynomolgus monkeys exposed chronically to diesel exhaust and coal dust. Fund. Appl. Toxicol. (1997) 37:37-53.
   PubMedGoogle Scholar
• NEMMAR A, VANBILLOEN H, HOYLAERTS MF, HOET PHM, VERBRUGGEN A, NEMERY B: Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am. J. Respir. Crit. Care Med. (2001) 164:1665-1668.
   PubMed Web of Science ®Google Scholar
• KREYLING WG, SEMMLER M, ERBE F et al.: Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J. Toxicol. Environ. Health (2002) 65:1513-1530.
   PubMed Web of Science ®Google Scholar
• NEMMAR P, HOET HM, VANQUICKENBORNE B, DINSDALE D, THOMEER M, HOYLAERTS MF: Passage of inhaled particles into the blood circulation in humans. Circulation (2002) 105:411-414.
   PubMed Web of Science ®Google Scholar
• BROWN LJS, ZEMAN KL, BENNETT WD: Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am. J. Respir. Crit. Care Med. (2002) 166:1240-1247.
   PubMed Web of Science ®Google Scholar
• MILLS NL, AMIN N, ROBINSON SD et al.: Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am. J. Respir. Crit. Care Med. (2006) 173(4):426-431.
   PubMed Web of Science ®Google Scholar
• VIDEIRA MA, BOTELHO MF, SANTOS AC, GOUVEIA LF, DE LIMA JJP, ALMEIDA AJ: Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J. Drug Target. (2002) 10(8):607-613.
   PubMed Web of Science ®Google Scholar
• MCINTIRE GL, BACON ER, TONER JL et al.: Pulmonary delivery of nanoparticles of insoluble, iodinated CT X-ray contrast agents to lung draining lymph nodes in dogs. J. Pharm. Sci. (1998) 87:1466-1470.
   PubMed Web of Science ®Google Scholar
• HANATANI K, TAKADA K, YOSHIDA N et al.: Molecular weight-dependent lymphatic transfer of flurescein isothiocyanate-labeled dextrans after intrapulmonary administration and effects of various absorption enhancers on the lymphatic transfer of drugs in rats. J. Drug Target. (1995) 3:263-271.
   PubMed Web of Science ®Google Scholar
• KIPEN HM, LASKIN DL: Smaller is not always better: nanotechnology yields nanotoxicology. Am. J. Physiol. Lung Cell. Mol. Physiol. (2005) 289(5):L696-L697.
   PubMed Web of Science ®Google Scholar
• SERVICE RF: Nanotoxicology: nanotechnology grows up. Science (2004) 304(5678):1732-1734.
   PubMed Web of Science ®Google Scholar
• BORM PJA: Particle toxicology: from coal mining to nanotechnology. Inhal. Toxicol. (2002) 14(3):311-324.
   PubMed Web of Science ®Google Scholar
• FERIN J, OBERDÖRSTER G, PENNEY DP, SODERHOLM SC, GELEIN R, PIPER HC: Increased pulmonary toxicity of ultrafine particles. I. Particle clearance, translocation, morphology. J. Aerosol Sci. (1990) 21:381-384.
   Web of Science ®Google Scholar
• DOCKERY DW, POPE CA, XU X et al.: An association between air pollution and mortality in six US cities. N. Engl. J. Med. (1993) 329:1753-1759.
   PubMed Web of Science ®Google Scholar
• BORM PJA, KREYLING W: Toxicological hazards of inhaled nanoparticles – potential implications for drug delivery. J. Nanosci. Nanotechnol. (2004) 4(5):521-531.
   PubMed Web of Science ®Google Scholar
• DONALDSON K, BROWN D, CLOUTER A et al.: The pulmonary toxicology of ultrafine particles. J. Aerosol Med. (2002) 15(2):213-220.
   PubMedGoogle Scholar
• MULLER J, HUAUX F, LISON D: Respiratory toxicity of carbon nanotubes: how worried should we be? Carbon (2006) 44(6):1048-1056.
   Web of Science ®Google Scholar
• HOET PH, BRÜSKE-HOHLFELD I, SALATA OV: Nanoparticles – known and unknown health risks. J. Nanobiotechnol. (2004) 2:1-15.
   PubMedGoogle Scholar
• ROM WN: Environmental and Occupational Medicine. Lippincott-Raven, Philadelphia (1998).
   Google Scholar
• HURLEY JF, ALEXANDER WP, HAZLEDINE DJ, JACOBSEN M, MACLAREN WM: Exposure to respirable coalmine dust and incidence of progressive massive fibrosis. Br. J. Ind. Med. (1987) 44:661-672.
   PubMedGoogle Scholar
• KREILGAARD M: Influence of microemulsions on cutaneous drug delivery. Adv. Drug Deliv. Rev. (2002) 54:S77-S98.
   PubMed Web of Science ®Google Scholar
• BEGLEY DJ: Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol. Ther. (2004) 104:29-45.
   PubMed Web of Science ®Google Scholar
• LOMBARDI BORGIA S, REGEHLY M, SIVARAMAKRISHNAN R et al.: Lipid nanoparticles for skin penetration enhancement – correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J. Control. Rel. (2005) 110(1):151-163.
   PubMed Web of Science ®Google Scholar
• MOOLGAVKAR SH, TURIM J, BROWN RC, LUEBECK GE: Long man-made fibres and lung cancer risk. Regul. Toxicol. Pharmacol. (2001) 33:138-146.
   PubMed Web of Science ®Google Scholar
• RENWICK LC, DONALDSON K, CLOUTER A: Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol. Appl. Pharmacol. (2001) 172:119-127.
   PubMed Web of Science ®Google Scholar
• WICHMANN G, MÜHLENBERG J, FISCHÄDER G et al.: An experimental model for the determination of immunomodulating effects by volatile compounds. Toxicol. In Vitro (2005) 19:685-693.
   PubMed Web of Science ®Google Scholar
• PENTTINEN P, TIMONEN KL, TIITTANEN P, MIRME A, RUUSKANEN J, PEKKANEN J: Ultrafine particles in urban air and respiratory health among adult asthmatics. Eur. Respir. J. (2001) 17:428-435.
   PubMed Web of Science ®Google Scholar
• VON KLOT S, WOLKE G, TUCH T, HEINRICH J, DOCKERY DW, SCHWARTZ J: Increased asthma medication use in association with ambient fine and ultrafine particles. Eur. Respir. J. (2002) 20:691-702.
   PubMed Web of Science ®Google Scholar
• TIITTANEN P, TIMONEN KL, RUUSKANEN J, MIRME A, PEKKANEN J: Fine particulate air pollution, resuspended road dust and respiratory health among symptomatic children. Eur. Respir. J. (1999) 13:266-273.
   PubMed Web of Science ®Google Scholar
• NEMMAR A, HOYLAERTS MF, HOET PHM, NEMERY B: Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol. Lett. (2004) 149:243-253.
   PubMed Web of Science ®Google Scholar
• GEYS J, COENEGRACHTS L, VERCAMMEN J et al.: In vitro study of the pulmonary translocation of nanoparticles: a preliminary study. Toxicol. Lett. (2006) 160(3):218-226.
   PubMed Web of Science ®Google Scholar
• NEMMAR A, HAMOIR J, NEMERY B, GUSTIN P: Evaluation of particle translocation across the alveolo-capillary barrier in isolated perfused rabbit lung model. Toxicol. Appl. Pharmacol. (2005) 208:105-113.
   Google Scholar
• GRANUM GB, LØVIK M: The effect of particles on allergic immune responses. Toxicol. Sci. (2002) 65:7-17.
   PubMed Web of Science ®Google Scholar
• OBERDÖRSTER G, UTELL MJ: Ultrafine particles in the urban air: to the respiratory tract – and beyond? Environ. Health Perspect. (2002) 110:A440-A441.
   PubMed Web of Science ®Google Scholar
• DONALDSON K, STONE V, TRAN CL, KREYLING W, BORM PJA: Nanotoxicology. Occup. Environ. Med. (2004) 61:727-728.
   PubMed Web of Science ®Google Scholar
• WARHEIT DB: Nanoparticles: health impacts? Mater. Today (2004) 7:32-35.
   Web of Science ®Google Scholar
• BORM PJA, ALBRECHT C, DROMMER W: Lung tumor formation in rats after intratracheal instillation of fine and ultrafine particles. Toxicol. Lett. (2003) 144:S105-S106.
   PubMed Web of Science ®Google Scholar
• MARK D: Nanomaterials – a risk to health at work? 1st International Symposium on Occupational Health Implications of Nanomaterials, Health and Safety Laboratory. Buxton, UK (12 – 14 October 2004).
   Google Scholar
• MEHTA D, BHATTACHARYA J, MATTHAY MA, MALIK AB: Integrated control of lung fluid balance. Am. J. Physiol. Lung Cell Mol. Physiol. (2004) 287:1081-1090.
   PubMed Web of Science ®Google Scholar
• HECKEL H, KIEFMANN R, DORGER M, STOECKELHUBER M, GOETZ AE: Colloidal gold particles as a new in vivo marker of early acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. (2004) 287:867-878.
   PubMed Web of Science ®Google Scholar
• FERIN J, OBERDÖRSTER G: Translocation of particles from pulmonary alveoli into the interstitium. J. Aerosol Med. (1992) 5:179-187.
   Google Scholar
• WEBB DR, WILSON SE, CARTER DE: Comparative pulmonary toxicity of gallium arsenide, gallium (III) oxide, or arsenic (III) oxide intratracheally instilled into rats. Toxicol. Appl. Pharmacol. (1986) 82:405-416.
   PubMed Web of Science ®Google Scholar
• WOLFF RK, HENDERSON RF, EIDSON AF, PICKRELL JA, ROTHENBERG SJ, HAHN FF: Toxicity of gallium oxide particles following a 4-week inhalation exposure. J. Appl. Toxicol. (1988) 8:191-199.
   PubMed Web of Science ®Google Scholar
• FERIN J, OBERDÖRSTER G, SODERHOLM SC, GELEIN R: Pulmonary tissue access of ultrafine particles. J. Aerosol Med. (1991) 4:57-68.
   Google Scholar
• ZHANG Q, KUSAKA Y, DONALDSON K: Comparative pulmonary responses caused by exposure to standard cobalt and ultrafine cobalt. J. Occup. Health (2000) 42:179-184.
   Web of Science ®Google Scholar
• ZHANG Q, KUSAKA Y, ZHU X et al.: Comparative toxicity of standard nickel and ultrafine nickel in lung after intratracheal instillation. J. Occup. Health (2003) 45:23-30.
   PubMed Web of Science ®Google Scholar
• BERRY JP, ARNOUX B, STANISLAS G, GALLE P, CHRETIEN J: A microanalytic study of particles transport across the alveoli: role of blood platelets. Biomedicine (1977) 27:354-357.
   PubMedGoogle Scholar
• OBERDÖRSTER G, FERIN R, GELEIN J, SODERHOLM SC, FINKELSTEIN JN: Role of the alveolar macrophage in lung injury – studies with ultrafine particles. Environ. Health Perspect. (1992) 97:193-199.
   PubMed Web of Science ®Google Scholar
• BROWN DM, WILSON MR, MACNEE W, STONE V, DONALDSON K: Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol. Appl. Pharmacol. (2001) 175:191-199.
   PubMed Web of Science ®Google Scholar
• DUFFIN R, TRAN CL, CLOUTER A et al.: The importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Ann. Occup. Hyg. (2002) 46:242-245.
   Google Scholar
• HEINRICH U, FUHST R, RITTINGHAUSEN S et al.: Chronic inhalation exposure of wistar rats and 2 different strains of mice to diesel-engine exhaust, carbon-black, and titanium-dioxide. Inhal. Toxicol. (1995) 7:533-556.
   Web of Science ®Google Scholar
• NIKULA KJ, SNIPES MB, BARR EB, GRIFFTH WC, HENDERSON RF, MAUDERLY JL: Comparative pulmonary toxicities and carcinogenenicities of chronically inhaled diesel exhaust and carbon black in F344 rats. Fund. Appl. Toxicol. (1995) 25:80-94.
   PubMedGoogle Scholar
• WARHEIT DB, WEBB TR, SAYES CM, COLVIN VL, REED KL: Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area. Toxicol. Sci. (2006) 91(1):227-236.
   PubMed Web of Science ®Google Scholar
• WEDA M, ZANEN P, DE BOER AH et al.: Equivalence testing of salbutamol dry powder inhalers: in vitro impaction results versus in vivo efficacy. Int. J. Pharm. (2002) 249(1-2):247-255.
   PubMedGoogle Scholar
• WEDA M, ZANEN P, DE BOER AH, BARENDS DM, FRIJLINK HW: An investigation into the predictive value of cascade impactor results for side effects of inhaled salbutamol. Int. J. Pharm. (2004) 287(1-2):79-87.
   PubMed Web of Science ®Google Scholar
• DRISCOLL KE: Mechanisms of rat lung tumors after chronic particle exposure: role of persistent inflammation. Inhal. Toxicol. (1996) S8:139-153.
   Google Scholar
• CASTRANOVA V: From coal mine dust to quartz: mechanisms of pulmonary pathogenicity. Inhal. Toxicol. (2000) 12:S7-S14.
   PubMed Web of Science ®Google Scholar
• SAYES CM, FORTNER JD, GUO W et al.: The differential cytoxocity of water-soluble fullerenes. Nano Lett. (2004) 4(10):881-1807.
   Web of Science ®Google Scholar
• CALVERT P: Strength in disunity. Nature (1992) 357:365-366.
   Web of Science ®Google Scholar
• COLES GV: Occupational risks. Nature (1992) 359:399.
   Web of Science ®Google Scholar
• CHEN X, TAM UC, CZLAPINSKI JL et al.: Interfacing carbon nanotubes with living cells. J. Am. Chem. Soc. (2006) 128(19):6292-6293.
   PubMed Web of Science ®Google Scholar
• HURT RH, MONTHIOUX M, KANE A: Toxicology of carbon nanomaterials: status, trends, and perspectives on the special issue. Carbon (2006) 44(6):1028-1033.
   Web of Science ®Google Scholar
• WARHEIT DB, LAURENCE B, REED KL, ROACH DH, REYNOLDS GAM, WEBB TR: Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci. (2004) 77:117-125.
   PubMed Web of Science ®Google Scholar
• MONARCA S, CREBELLI R, FERETTI D et al.: Mutagens and carcinogens in size-classified air particulates of a Northern Italian town. Sci. Total Environ. (1997) 205:137-144.
   PubMed Web of Science ®Google Scholar
• DICK CAJ, BROWN DM, DONALDSON K, STONE V: The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types. Inhal. Toxicol. (2003) 15:39-52.
   PubMed Web of Science ®Google Scholar
• GEISER M, SCHÜRCH S, GEHR P: Influence of surface chemistry and topography of particles on their immersion into the lung's surface-lining layer. J. Appl. Physiol. (2003) 94:1793-1801.
   PubMed Web of Science ®Google Scholar
• GEHR P, GEISER M, HOF VI, SCHÜRCH S: Surfactant-ultrafine particle interactions: what we can learn from PM10 studies. Philos. Trans. Math. Phys. Eng. Sci. (2000) 358:2707-2718.
   Web of Science ®Google Scholar
• DICK CA, SINGH P, DANIELS M, EVANSKY P, BECKER S, GILMOUR I: Murine pulmonary inflammatory responses following instillation of size-fractionated ambient particulate matter. J. Toxicol. Environ. Health A (2003) 66:2193-2207.
   PubMed Web of Science ®Google Scholar
• MACNEE W, DONALDSON K: Mechanism of lung injury caused by PM10 and ultrafine particles with special referance to COPD. Eur. Respir. J. (2003) 21:47-51.
   Web of Science ®Google Scholar
• WARHEIT DB, WEBB TR, REED KL, SAYES C, COLVEN V: Pulmonary responses to nanoparticles: particle size is only one of several factors that influence toxicity. Proceedings of the Fall Symposium of the National Capital Area Chapter of the Society of Toxicology; Association of Government Toxicologists, and the National Capital Area Chapter of the Society for Risk Analysis. Bethesda, USA (2005).
   Google Scholar
• PISON U, WELTE T, GIERSIG M, GRONEBERG DA: Nanomedicine for respiratory diseases. Eur. J. Pharmacol. (2006) 533(1-3):341-350.
   PubMed Web of Science ®Google Scholar
• OSTRANDER KD, BOSCH H, BONDANZA D: An in vitro assessment of a NanoCrystalTM beclomethasone dipropionate colloidal dispersion via ultrasonic nebulization. Eur. J. Pharm. Biopharm. (1999) 48:207-215.
   PubMed Web of Science ®Google Scholar
• KRAFT WK, STEIGER B, BEUSSINK D et al.: The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers. J. Clin. Pharmacol. (2004) 44:67-72.
   PubMed Web of Science ®Google Scholar
• HOEBEN BJ, BURGESS DS, MCCONVILLE JT et al.: In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. (2006) 50(4):1552-1554.
   PubMed Web of Science ®Google Scholar
• AZARMI S, TAO X, CHEN H et al.: Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. Int. J. Pharm. (2006) 319:155-161.
   PubMed Web of Science ®Google Scholar